EW Edwards Lifesciences Corporation

101.85USD-1.95%Mkt Cap: 58.56B USDP/E: 59.22

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement prod…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap58.56B USD
Enterprise Value55.89B USD
Revenue (TTM)6.67B USD
Gross Profit4.73B USD
Net Income (TTM)1.07B USD
Revenue/Share11.54 USD
Last Price101.85 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees16.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)59.22
P/E (Forward)30.08
PEG2.32
EV/EBITDA26.68
EV/Revenue8.37
P/S8.77
P/B5.40
EPS (TTM)1.72 USD
EPS (Forward)3.39 USD
52W Range
74.6682% of range108.00
52W High108.00 USD
52W Low74.66 USD
Profitability
Gross Margin78.01%
Oper. Margin28.82%
EBITDA Margin31.38%
Profit Margin17.69%
ROE10.38%
ROA7.84%
ROIC19.91%
ROCE13.77%
Growth
Revenue Growth10.50%
Earnings Growth6.70%
Cash Flow & Leverage
Operating CF1.60B USD
CapEx (TTM)260.20M USD
FCF Margin17.16%
FCF Yield1.96%
Net Debt-3.94B USD
Net Debt/EBITDA-1.88
Net Debt/FCF-3.44
Balance Sheet
Debt/Equity0.07
Current Ratio4.60
Quick Ratio3.54
Book Value/Sh18.87 USD
Cash/Share8.08 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split3:1
Split DateJun 1, 2020
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)113.83 USD
Upside (mean)+11.8%
Target Range84.00 USD – 126.00 USD
84.00+11.8% to mean126.00
# Analysts27
Ownership
Shares Out.575.00M
Float573.23M
Insiders0.40%
Institutions94.67%
Short Interest
Short Ratio2.6d
Short % Float1.86%
Short % Out.1.63%
Shares Short9.38M
Short (prev mo.)9.54M
Technical
SMA 5091.52 (+11.3%)
SMA 20086.69 (+17.5%)
Beta0.83
S&P 52W Chg12.00%
Avg Vol (30d)4.45M
Avg Vol (10d)4.98M
Technical Indicators
RSI (14)59.2
MACD3.9915
MACD Signal4.1848
MACD Hist.-0.1932
BB Upper112.14 USD
BB Middle100.07 USD
BB Lower87.99 USD
BB Width24.13%
ATR (14)2.782 USD
Vol Ratio (20d)0.70x

About Edwards Lifesciences (NYSE: EW)

›

Edwards Lifesciences (NYSE: EW) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 16,000 employees.

The shares were at 101.85 USD on 20 November 2026, up 20.2% over 52 weeks. Its 52-week range is 74.66 USD to 108.00 USD: the price is 5.7% below the high and 36.4% above the low.

At a market capitalisation of 58.56B USD, it trades at 59.2 times trailing earnings and 30.1 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 24.9, a premium of 138% for EW.

Edwards Lifesciences reports return on equity of 10.4%, an operating margin of 28.8% and revenue up 10.5% year over year.

It holds more cash than debt, a net cash position of 3.94B USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 27 analysts cover the stock, with an average rating of Buy; their mean price target of 113.83 USD is 11.8% above the current price. The next earnings report is expected on 9 February 2027.